Global Radiopharmaceuticals Market to Grow at a CAGR of 9.02% to 2021 adds “Global Radiopharmaceuticals Market 2017-2021” new report to its research database. The report spread across 83 pages with table and figures in it.

Research analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.

Covered in this report
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
Browse full table of contents and data tables at

The market is divided into the following segments based on geography:

Technavio’s report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Technavio Announces the Publication of its Research Report – Global Radiopharmaceuticals Market 2017-2021

Technavio recognizes the following companies as the key players in the global radiopharmaceuticals market: Bayer, Cardinal Health, GE Healthcare, and Lantheus Medical Imaging.

Other Prominent Vendors in the market are: ABT Molecular Imaging, Advanced Accelerator Applications, Algeta, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, Isologic Innovative Radiopharmaceuticals, Nordion, Piramal Imaging, RadioMedix, and Triad Isotopes.

Commenting on the report, an analyst from Research team said: “The latest trend gaining momentum in the market is Partnerships for development of radiopharmaceuticals. Some of the leading nuclear medicines and nuclear imaging companies are forming partnerships to solve long-standing radiopharmaceutical concerns in medical imaging and increase their market share. These partnerships will increase the production of low-cost radiopharmaceuticals, which will boost the growth of the market.”

Order a Purchase Report Copy at

According to the report, one of the major drivers for this market is Rising burden of the neurological disorders. Neurological disorders are diseases that are related to the brain, spine, and the nerves. There are over 600 diseases of the nervous system, some of the most common diseases are epilepsy, Parkinson’s disease, brain tumors, and stroke; while some of the less familiar ones include frontotemporal dementia.

Further, the report states that one of the major factors hindering the growth of this market is Shortage of radioisotopes. Mo-99 is a precursor of Tc-99, and its half-life is 66 hours, which after decaying, forms Tc-99. It emits gamma rays, which help clinicians create images for diagnosis and monitor the spread of disease. Tc-99 is used in more than 40 million imaging procedures globally, which covers around 72% of all procedures in nuclear medicine. However, shortage of few important radioisotopes such as Mo-99 has an adverse effect on the global radiopharmaceuticals market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Enquiry before Buying Copy at

About: is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on industries, organizations, products, and trends.


Mr. Jeet Jain

Sales Manager



Connect with us:  Google+ | LinkedIn | Twitter | Facebook